Radiology Practices Grapple with AI Rollouts

The U.S. Food and Drug Administration has authorized a rapidly growing number of AI-powered tools for radiology, with the total number of approved AI/ML medical devices reaching 950, 76% of which are for radiology. This surge is dominated by major manufacturers like GE HealthCare and Siemens Healthineers, with nearly all devices gaining clearance through the 510(k) pathway, which streamlines market entry. Despite the flood of new technology, clinical adoption in the United States remains low, with some 2024 estimates suggesting only about 2% of radiology practices have integrated AI reading tools. This contrasts sharply with Europe, where a 2024 survey found that 48% of radiologists are actively using AI tools in their practice, up from just 20% in 2018. Where implemented, AI is demonstrating tangible productivity gains by automating repetitive tasks and triaging worklists. One study showed AI assistance reduced the time to interpret chest X-rays by over 35%, while another generative AI tool boosted report completion efficiency by an average of 15.5%, with some radiologists seeing gains as high as 40%. This technological push coincides with a major site-of-care shift, with 40% of all radiology volume now performed in outpatient settings. Projections show advanced outpatient imaging, particularly CT and PET scans, is expected to grow by 13-14% over the next decade as health systems increasingly pursue strategies like joint ventures to expand their freestanding imaging footprint. However, this outpatient boom faces significant financial headwinds from declining reimbursements. The 2025 Medicare Physician Fee Schedule includes a reduced conversion factor, impacting payment rates for many high-volume procedures like MRI, CT, and ultrasound. This continues a decade-long trend that has seen inflation-adjusted Medicare payments for diagnostic radiology fall by over 44%. In response to these pressures, outpatient imaging centers are focused on operational efficiency and service diversification, expanding into higher-demand modalities like PET/CT and interventional procedures. The market is also seeing significant consolidation, with private equity firms and large networks like RadNet and SimonMed pursuing aggressive acquisition strategies, making imaging IT contracts larger and more complex.